Iqvia easily belongs in the top tier of large, global CROs with the infrastructure to win these contracts, and its size means it works on more clinical trials than any competitor, further sharpening ...

Ready Capital (RC) faces portfolio challenges with unsustainable dividends and questionable capital allocation. Click here to ...